PL2155677T3 - Sole monochlorowodorowe inhibitora deacetylazy histonowej - Google Patents

Sole monochlorowodorowe inhibitora deacetylazy histonowej

Info

Publication number: PL2155677T3
Authority: PL; Poland
Prior art keywords: mono; inhibitor; histone deacetylase; hydrochloric salts; hydrochloric
Prior art date: 2007-05-14

Application number

PL08750252T

Other languages

English (en)

Inventor

Julius W J Dickens

Ioannes Nicolaos Houpis

Yolande Lydia Lang

Carina Leys

Sigrid Carl Maria Stokbroekx

Johan Erwin Edmond Weerts

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-14

Filing date

2008-05-13

Publication date

2015-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38659779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2155677(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-05-13 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2015-03-31 Publication of PL2155677T3 publication Critical patent/PL2155677T3/pl

Links

102000003964 Histone deacetylase Human genes 0.000 title 1
108090000353 Histone deacetylase Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL08750252T 2007-05-14 2008-05-13 Sole monochlorowodorowe inhibitora deacetylazy histonowej PL2155677T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US91782107P	2007-05-14	2007-05-14
EP07108176		2007-05-14
EP08750252.2A EP2155677B1 (en)	2007-05-14	2008-05-13	Mono-hydrochloric salts of an inhibitor of histone deacetylase
PCT/EP2008/055804 WO2008138918A1 (en)	2007-05-14	2008-05-13	Mono-hydrochloric salts of an inhibitor of histone deacetylase

Publications (1)

Publication Number	Publication Date
PL2155677T3 true PL2155677T3 (pl)	2015-03-31

Family

ID=38659779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08750252T PL2155677T3 (pl)	2007-05-14	2008-05-13	Sole monochlorowodorowe inhibitora deacetylazy histonowej

Country Status (32)

Country	Link
US (2)	US20100130523A1 (pl)
EP (1)	EP2155677B1 (pl)
JP (1)	JP2010526851A (pl)
KR (1)	KR101540679B1 (pl)
CN (1)	CN101679256B (pl)
AP (1)	AP2717A (pl)
AR (2)	AR066550A1 (pl)
AU (1)	AU2008250047B2 (pl)
BR (1)	BRPI0811859B8 (pl)
CA (1)	CA2683195C (pl)
CL (1)	CL2008001390A1 (pl)
CO (1)	CO6140031A2 (pl)
CR (1)	CR11163A (pl)
CY (1)	CY1115837T1 (pl)
DK (1)	DK2155677T3 (pl)
EA (1)	EA018326B1 (pl)
EC (1)	ECSP099729A (pl)
ES (1)	ES2525456T3 (pl)
HR (1)	HRP20141180T1 (pl)
IL (1)	IL202042A0 (pl)
JO (1)	JO2959B1 (pl)
MX (1)	MX2009012332A (pl)
NZ (1)	NZ599674A (pl)
PA (1)	PA8780301A1 (pl)
PL (1)	PL2155677T3 (pl)
PT (1)	PT2155677E (pl)
RS (1)	RS53672B1 (pl)
SG (1)	SG182986A1 (pl)
SI (1)	SI2155677T1 (pl)
TW (1)	TWI414294B (pl)
UA (1)	UA100510C2 (pl)
WO (1)	WO2008138918A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009015917A2 (en)	2007-05-14	2009-02-05	F. Hoffmann-La Roche Ag	Dihydroquinone and dihydronaphthridine inhibitors of jnk

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5924990B2 (ja) *	1979-11-21	1984-06-13	協和醗酵工業株式会社	新規なピペリジン誘導体
SK283335B6 (sk)	1995-12-08	2003-06-03	Janssen Pharmaceutica N. V.	(Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
US8008302B2 (en) *	2004-07-26	2011-08-30	Merck Serono Sa	N-hydroxyamide derivatives and use thereof
KR101261305B1 (ko) *	2004-07-28	2013-05-08	얀센 파마슈티카 엔.브이.	히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체

2008
- 2008-05-06 JO JO2008202A patent/JO2959B1/en active
- 2008-05-12 PA PA20088780301A patent/PA8780301A1/es unknown
- 2008-05-12 CL CL2008001390A patent/CL2008001390A1/es unknown
- 2008-05-13 RS RS20140662A patent/RS53672B1/sr unknown
- 2008-05-13 DK DK08750252.2T patent/DK2155677T3/en active
- 2008-05-13 CN CN2008800163514A patent/CN101679256B/zh active Active
- 2008-05-13 UA UAA200910196A patent/UA100510C2/ru unknown
- 2008-05-13 PT PT87502522T patent/PT2155677E/pt unknown
- 2008-05-13 BR BRPI0811859A patent/BRPI0811859B8/pt active IP Right Grant
- 2008-05-13 HR HRP20141180AT patent/HRP20141180T1/hr unknown
- 2008-05-13 AU AU2008250047A patent/AU2008250047B2/en active Active
- 2008-05-13 KR KR1020097021648A patent/KR101540679B1/ko active Active
- 2008-05-13 JP JP2010507895A patent/JP2010526851A/ja active Pending
- 2008-05-13 PL PL08750252T patent/PL2155677T3/pl unknown
- 2008-05-13 AR ARP080102021A patent/AR066550A1/es active IP Right Grant
- 2008-05-13 AP AP2009005039A patent/AP2717A/xx active
- 2008-05-13 MX MX2009012332A patent/MX2009012332A/es active IP Right Grant
- 2008-05-13 TW TW097117494A patent/TWI414294B/zh active
- 2008-05-13 CA CA2683195A patent/CA2683195C/en active Active
- 2008-05-13 EP EP08750252.2A patent/EP2155677B1/en active Active
- 2008-05-13 SI SI200831339T patent/SI2155677T1/sl unknown
- 2008-05-13 EA EA200971031A patent/EA018326B1/ru unknown
- 2008-05-13 US US12/598,743 patent/US20100130523A1/en not_active Abandoned
- 2008-05-13 NZ NZ599674A patent/NZ599674A/xx unknown
- 2008-05-13 ES ES08750252.2T patent/ES2525456T3/es active Active
- 2008-05-13 SG SG2012048781A patent/SG182986A1/en unknown
- 2008-05-13 WO PCT/EP2008/055804 patent/WO2008138918A1/en not_active Ceased
2009
- 2009-09-30 CO CO09107340A patent/CO6140031A2/es unknown
- 2009-11-11 EC EC2009009729A patent/ECSP099729A/es unknown
- 2009-11-11 IL IL202042A patent/IL202042A0/en active IP Right Grant
- 2009-12-14 CR CR11163A patent/CR11163A/es not_active Application Discontinuation
2012
- 2012-05-30 US US13/483,678 patent/US8759519B2/en active Active
2014
- 2014-12-17 CY CY20141101062T patent/CY1115837T1/el unknown
2020
- 2020-03-13 AR ARP200100716A patent/AR118361A2/es active IP Right Grant

Also Published As

Publication number	Publication date
AU2008250047A1 (en)	2008-11-20
CO6140031A2 (es)	2010-03-19
BRPI0811859B8 (pt)	2021-05-25
BRPI0811859A2 (pt)	2014-11-18
US20100130523A1 (en)	2010-05-27
SI2155677T1 (sl)	2015-01-30
AU2008250047B2 (en)	2013-01-17
EA200971031A1 (ru)	2010-04-30
UA100510C2 (ru)	2013-01-10
PA8780301A1 (es)	2008-12-18
KR101540679B1 (ko)	2015-07-30
IL202042A0 (en)	2010-06-16
PT2155677E (pt)	2014-12-23
AP2009005039A0 (en)	2009-12-31
JO2959B1 (en)	2016-03-15
CY1115837T1 (el)	2017-01-25
CL2008001390A1 (es)	2008-11-21
SG182986A1 (en)	2012-08-30
AR066550A1 (es)	2009-08-26
DK2155677T3 (en)	2015-01-05
ES2525456T3 (es)	2014-12-23
WO2008138918A1 (en)	2008-11-20
AP2717A (en)	2013-07-31
HK1140479A1 (en)	2010-10-15
EA018326B1 (ru)	2013-07-30
ECSP099729A (es)	2009-12-28
EP2155677B1 (en)	2014-10-01
US8759519B2 (en)	2014-06-24
EP2155677A1 (en)	2010-02-24
US20120289527A1 (en)	2012-11-15
BRPI0811859B1 (pt)	2020-02-11
CN101679256B (zh)	2013-06-26
AR118361A2 (es)	2021-09-29
KR20100015647A (ko)	2010-02-12
JP2010526851A (ja)	2010-08-05
MX2009012332A (es)	2009-12-01
TWI414294B (zh)	2013-11-11
HRP20141180T1 (hr)	2015-02-13
RS53672B1 (sr)	2015-04-30
NZ599674A (en)	2013-02-22
CA2683195C (en)	2016-08-09
TW200914024A (en)	2009-04-01
CA2683195A1 (en)	2008-11-20
CR11163A (es)	2010-05-27
CN101679256A (zh)	2010-03-24

Publication	Publication Date	Title
EP2217588A4 (en)	2013-12-04	INHIBITORS OF HISTONE DEACETYLASE
ZA200906609B (en)	2010-05-26	Inhibitors of histone deacetylase
EP2134680A4 (en)	2012-03-07	Histone deacetylase INHIBITORS
ZA201002841B (en)	2010-12-29	Histone deacetylase inhibitors
EP2265590B8 (en)	2016-07-27	Selective inhibitors of histone deacetylase
IL193458A0 (en)	2009-08-03	Histone deacetylase inhibitors
EP2451790A4 (en)	2012-12-26	INHIBITORS OF HISTONE DEACETYLASE
EP1973872A4 (en)	2012-05-09	HISTONDEACETYLASE HEMMER AND PROPHARMAKA THEREOF
AU2008300827A8 (en)	2010-06-03	Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
IL198263A0 (en)	2009-12-24	Hydroxamates as inhibitors of histone deacetylase
IL188692A0 (en)	2008-08-07	Histone deacetylase inhibitors
BRPI0916713A2 (pt)	2015-11-10	compostos inibidores de histona desacetilase de cicloalquilideno e heterocicloalquilideno
EP1735319A4 (en)	2010-06-09	Histone deacetylase INHIBITORS
EP1755601A4 (en)	2009-12-02	HISTONE DEACETYLASE INHIBITORS
IL199727A0 (en)	2010-04-15	Inhibitors of mek
EP1991226A4 (en)	2012-01-25	Histone deacetylase INHIBITORS
IL210804A0 (en)	2011-04-28	Deacetylase inhibitors and uses thereof
BRPI0909159A2 (pt)	2015-11-24	inibidores baseados em hidroxamato de desacetilases b
BRPI0821247A2 (pt)	2015-06-16	Inibidores de histona deacetilase
EP2205563A4 (en)	2012-01-25	NEW HISTONDEACETYLASE INHIBITORS
TWI365181B (en)	2012-06-01	Cinnamic compounds and derivatives therefrom for the inhibition of histone deacetylase
ZA201001972B (en)	2012-06-27	Novel teteahydrofusedpyridines as histone deacetylase inhibitors
IL202042A0 (en)	2010-06-16	Mono-hydrochloric salts of an inhibitor of histone deacetylase
GB0620823D0 (en)	2006-11-29	Histone deacetylase inhibitors
PT2045247E (pt)	2015-06-09	Compostos para a inibição da histona-desacetilase